Archive · 23 Jan 2026
Linux Labs Raises $70M for Expansion
Linux Laboratories, a company that makes medicines for the brain and skin, is trying to get $50-70 million to grow bigger.
They want to sell more medicines in India and other countries.
A company called Avendus is helping them with this.
Linux already makes a lot of money from selling medicines, and they want to make even more.
They compete with other big medicine companies in India.
The Indian medicine market is growing fast, and Linux wants to be a big part of it.
Linux Laboratories aims to raise $50-70 million for expansion.
Avendus appointed as adviser for the capital raise.
Company specializes in CNS, dermatology, and other medical fields.
Revenue grew to ₹285 crore in FY25, with a profit of ₹26 crore.
Plans include international expansion and strengthening existing categories.
- Who
- Linux Laboratories, a Chennai-based pharmaceutical company
- What
- Raising $50-70 million for expansion
- When
- Expected soon, second round in over four years
- Where
- India, with plans to expand internationally
- Why
- To fund expansion, organic and inorganic growth, and widen footprint
- Company
- Linux Laboratories
- Founded
- 2007
- Founders
- Keerthivasan K. and Ananda Kumar
- Specialization
- CNS, dermatology, neutraceuticals, cardio
- Revenue (FY25)
- ₹285 crore
- Profit (FY25)
- ₹26 crore
- Target Fundraising
- $50-70 million
- Adviser
- Avendus